Agilent Technologies

Healthcare  |  Diagnostics & Research
75.46 0.0 0.0%
Stock Price | Oct. 21, 2019, 3:59 p.m.
1 Follower
Bid: 0.0
Ask: 0.0
Prev. Close: 75.46
52 Week Low: 61.01
52 Week High: 82.27
PE Ratio: 22.598802
Dividend Yield: 87.0%

Company Summary

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (46% of fiscal 2018 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (19%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse with operations in the U.S. (29%) and China (21%) representing the largest country concentrations.

Read more Read less

Recently Viewed Tickers

Premium Changes to the Global Cannabis Stock Index

3 weeks ago

Free test post

2 months ago

Premium Weekly Review 08/09/19

2 months ago

Free alan video test

7 months ago

Free Test

12 months ago

Premium Test

1 year ago
4 years ago

Free Unusual Covered Call Idea Agilent (A)

4 years ago